Injection device

- HALOZYME, INC.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective view of an injection device showing our new design;

FIG. 2 is a rear perspective view thereof;

FIG. 3 is a front elevational view thereof;

FIG. 4 is a rear elevational view thereof;

FIG. 5 is a left-side elevational view thereof;

FIG. 6 is a right-side elevational view thereof;

FIG. 7 is a top plan view thereof; and,

FIG. 8 is a bottom plan view thereof.

The broken lines depict portions of the injection device that form no part of the claimed design.

Claims

The ornamental design for an injection device, as shown and described.

Referenced Cited
U.S. Patent Documents
D729930 May 19, 2015 Geert-Jensen
D734450 July 14, 2015 Geert-Jensen
D752738 March 29, 2016 Riess
D753291 April 5, 2016 Ratjen
D756506 May 17, 2016 Jones
D758571 June 7, 2016 Geert-Jensen
D765833 September 6, 2016 Geert-Jensen
D770038 October 25, 2016 Ahlgrim
D810283 February 13, 2018 Amend Kwasnik
D977989 February 14, 2023 Kim
D1006984 December 5, 2023 Hewson
20130218088 August 22, 2013 De Sausmarez Lintell
20140249482 September 4, 2014 Wieselblad
20170266384 September 21, 2017 Veasey
20180071460 March 15, 2018 Rekaya
20180079119 March 22, 2018 Morris
20230293821 September 21, 2023 Bengtsson
Foreign Patent Documents
303404889 October 2015 CN
015025494-0007 July 2023 EM
Other references
  • Vibex autoinjector, Halozyme, [Post date: Unknown], [Site seen: Apr. 25, 2024], Seen at URL: https://halozyme.com/drug-delivery-technologies/auto-injectors/ (Year: 2024).
  • Nest Reusable Pen Injector , nest-biotech, [Post date unknown], [Site seen: Apr. 25, 2024], Seen at URL: https://www.nest-biotech.com/insulin-pen-injector/63289079.html (Year: 2024).
  • TouStar® Reusable Pen Injector for Insulin | 2021, Sanofi Aventis, [Post date: Jun. 3, 2022], [Site seen: Apr. 25, 2024], Seen at URL: https://www.europeanarch.eu/green-good-design-awards-archive/2022/06/03/toustar®-reusable-pen-injector-for-insulin-2021/ (Year: 2022).
  • Office Action issued in corresponding Japanese Application No. 2023-012614, dated Aug. 16, 2023, 3 pages, with English translation.
Patent History
Patent number: D1042806
Type: Grant
Filed: Dec 22, 2022
Date of Patent: Sep 17, 2024
Assignee: HALOZYME, INC. (San Diego, CA)
Inventors: Todd J. Leadens, II (Maple Grove, MN), Baylor Frantz (Minnetonka, MN), Scott Beacher (St. Louis Park, MN), Kevin Swanson (Plymouth, MN), Mike Travanty (Wayzata, MN)
Primary Examiner: Natasha Vujcic
Assistant Examiner: Gilbert B Ford
Application Number: 29/869,164